Document is current
Any future updates will be listed below
-
Authors
Stavrev, Pavel https://orcid.org/0000-0001-5221-1035
Balabanova, Anna
Genova, Boriana
Stavreva, Nadejda
Ruggieri, Ruggero
Nahum, Alan E.
Parvanova, Vesselina
-
Funding
Funding for this research was provided by:
Bulgarian National Science Fund (DN 18/4 (10.12.2017))
- License Information
-
More Information
Article History
Received: 19 May 2020
Accepted: 30 March 2021
First Online: 9 April 2021
Declarations
:
: The authors declare that they have no conflict of interest.
: The patients included in the material of the publication (the period from 2011 to 2016) were not in a clinical study, but were treated for I stage prostate cancer according to the current treatment protocol in the country. The patients selected for this retrospective dosimetry study are approved by the Institutional Review Board (Ethics Committee of USBALO—Specialized Hospital for Active Treatment in Oncology).
: The Patients have signed an informed consent for the type of treatment that has been administered.
: Not applicable.
: Not applicable.
